Pioneering Novel Kinase Inhibitors: Facilitating CNS Penetration to Combat Neurodegenerative Diseases
Time: 9:00 am
day: Conference Day Two
Details:
- Understanding the unique characteristics of BTK inhibitors and degraders to enable translatability
- Maintaining neuroprotective functions of compounds to limit pleiotropic off-target effects common to BTK inhibitors and degraders
- Prioritizing efficacy over specific targets as a benchmark for optimizing compounds within in vitro models to successfully induce neuroprotection
